التفاصيل البيبلوغرافية
| العنوان: |
Dilute versus concentrated vasopressin administration during laparoscopic myomectomy: a randomised controlled trial. |
| المؤلفون: |
Cohen, SL, Senapati, S, Gargiulo, AR, Srouji, SS, Tu, FF, Solnik, J, Hur, H‐C, Vitonis, A, Jonsdottir, GM, Wang, KC, Einarsson, JI, Cohen, S L, Gargiulo, A R, Srouji, S S, Tu, F F, Hur, H-C, Jonsdottir, G M, Wang, K C, Einarsson, J I |
| المصدر: |
BJOG: An International Journal of Obstetrics & Gynaecology; Jan2017, Vol. 124 Issue 2, p262-268, 7p |
| مصطلحات موضوعية: |
VASOPRESSIN, MYOMECTOMY, BLOOD loss estimation, BENIGN tumors, CLINICAL trials, CHARTS, diagrams, etc., SURGICAL blood loss, COMPARATIVE studies, GYNECOLOGIC surgery, SURGICAL hemostasis, HEMOSTATICS, LAPAROSCOPY, RESEARCH methodology, MEDICAL cooperation, RESEARCH, UTERINE fibroids, UTERINE tumors, EVALUATION research, RANDOMIZED controlled trials, PREVENTION |
| مستخلص: |
Objective: To determine if higher-volume, fixed-dose administration of vasopressin further reduces blood loss at the time of minimally invasive myomectomy.Design: Randomised multicentre clinical trial.Setting: Tertiary-care academic centres in the USA.Population: Women undergoing conventional laparoscopic or robot-assisted laparoscopic myomectomy.Methods: All participants received the same 10-unit (U) dose of vasopressin, but were randomly assigned to one of two groups: (i) received 200 ml of diluted vasopressin solution (20 U in 400 ml normal saline), and (ii) received 30 ml of concentrated vasopressin solution (20 U in 60 ml normal saline).Main Outcome Measures: The primary study outcome was estimated blood loss; the study was powered to detect a 100-ml difference.Results: A total of 152 women were randomised; 76 patients in each group. Baseline demographics were similar between groups. The primary outcome of intraoperative blood loss was not significantly different, as measured by three parameters: surgeon estimate (mean estimated blood loss 178 ± 265 ml and 198 ± 232 ml, dilute and concentrated groups respectively, P = 0.65), suction canister-calculated blood loss, or change in haematocrit levels. There were no vasopressin-related adverse events.Conclusion: Both dilute and concentrated vasopressin solutions that use the same drug dosing demonstrate comparable safety and tolerability when administered for minimally invasive myomectomy; however, higher volume administration of vasopressin does not reduce blood loss.Tweetable Abstract: This randomised trial failed to show benefit of high-volume dilute vasopression. [ABSTRACT FROM AUTHOR] |
|
Copyright of BJOG: An International Journal of Obstetrics & Gynaecology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder